Phenotypic and genomic characterization of the Antarctic bacterium Gillisia sp. CAL575, a producer of antimicrobial compounds.

Microorganisms from Antarctica have evolved particular strategies to cope with cold. Moreover, they have been recently reported as producers of antimicrobial compounds, which inhibit the growth of other bacteria. In this work we characterized from different viewpoints the Gillisia sp. CAL575 strain,...

Full description

Bibliographic Details
Published in:Extremophiles
Main Authors: Maida I, Fondi M, Papaleo MC, Perrin E, Orlandini V, Emiliani G, de Pascale D, Michaud L, Lo Giudice A, Romoli R, Bartolucci G, Fani R., PARRILLI, ERMENEGILDA, TUTINO, MARIA LUISA
Other Authors: Maida, I, Fondi, M, Papaleo, Mc, Perrin, E, Orlandini, V, Emiliani, G, de Pascale, D, Parrilli, Ermenegilda, Tutino, MARIA LUISA, Michaud, L, Lo Giudice, A, Romoli, R, Bartolucci, G, Fani, R.
Format: Article in Journal/Newspaper
Language:English
Published: 2014
Subjects:
Antarctic bacterium
Gillisia sp. CAL575
Cystic fibrosi
Burkholderia cepacia complex
VOCs
Antarctic
The Antarctic
Antarc*
Antarctica
Online Access:http://hdl.handle.net/11588/573504
https://doi.org/10.1007/s00792-013-0590-0
Description
Summary:Microorganisms from Antarctica have evolved particular strategies to cope with cold. Moreover, they have been recently reported as producers of antimicrobial compounds, which inhibit the growth of other bacteria. In this work we characterized from different viewpoints the Gillisia sp. CAL575 strain, a psychrotrophic bacterium that produces microbial volatile organic compounds involved in the growth inhibition of Burkholderia cepacia complex members. Sequencing and analysis of the whole genome of Gillisia sp. CAL575 revealed that it includes genes that are involved in secondary metabolite production, adaptation to cold conditions, and different metabolic pathways for the production of energy. All these features make Gillisia sp. CAL575 a possible tool for biotechnology.

Similar Items